Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Amneal Pharma Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (358)

Date

2022 (49)
2021 (17)
2020 (22)
2019 (109)
2018 (78)
2017 (81)
2016 (1)
2015 (1)

Search

Sponsor content

358 result(s) found, displaying 351 to 358

FRUSEMIDE AN furosemide (frusemide) 20mg tablet bottle Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
FRUSEMIDE AN furosemide (frusemide) 40mg tablet bottle Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
FRUSEMIDE AN furosemide (frusemide) 20mg tablet bottle Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
FRUSEMIDE AN furosemide (frusemide) 40mg tablet bottle Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
FRUSEMIDE AN furosemide (frusemide) 20mg tablet bottle Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
FRUSEMIDE AN furosemide (frusemide) 40mg tablet bottle Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
IRINOTECAN ACTAVIS 100 irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial Cancelled under s30(1)(c)

27 December 2016

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
RALOXIFENE- CH Raloxifene hydrochloride 60 mg tablets, blister pack Cancelled under s30(1)(c )

12 March 2015

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd

Pages

First page
Previous page
…
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Current page 36

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.